Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 8

Results For "event"

2076 News Found

Machine Learning to understand and prevent disease
Digitisation | September 17, 2021

Machine Learning to understand and prevent disease

Barbara Engelhardt moves her computational and statistics lab to Gladstone


Honeywell launches solutions to prevent counterfeit pharma products
News | June 23, 2021

Honeywell launches solutions to prevent counterfeit pharma products

The end user can validate the authenticity of the product by scanning the digital code with the help of a smartphone letting the end user know it is safe to use


Akumentis Healthcare appoints Dharnendra Doshi as Senior Vice President
People | May 25, 2026

Akumentis Healthcare appoints Dharnendra Doshi as Senior Vice President

Veteran consumer health and FMCG strategist to lead preventive wellness and nutrition portfolio expansion through innovation and modern trade channels


Merck’s KEYTRUDA combo wins key EU backing for bladder cancer treatment
Drug Approval | May 25, 2026

Merck’s KEYTRUDA combo wins key EU backing for bladder cancer treatment

The decision now moves to the European Commission, with a final ruling expected by the third quarter of 2026


Oral GLP-1 race heats up as Lilly’s Foundayo shines in seniors
News | May 25, 2026

Oral GLP-1 race heats up as Lilly’s Foundayo shines in seniors

The company said all doses achieved statistically significant reductions in body weight compared with placebo at 72 weeks


WHO declares Ebola outbreak, Indians advised against travel to affected regions
Public Health | May 25, 2026

WHO declares Ebola outbreak, Indians advised against travel to affected regions

No approved vaccine or specific treatment currently available for Bundibugyo strain Ebola disease


EU regulator backs Allergan Aesthetics’ Boey in key step toward approval
Drug Approval | May 25, 2026

EU regulator backs Allergan Aesthetics’ Boey in key step toward approval

The decision marks a key step in the centralized EU review process


Lilly brings heavy oncology firepower to ASCO with plenary data across cancers
R&D | May 25, 2026

Lilly brings heavy oncology firepower to ASCO with plenary data across cancers

The company is also highlighting early-stage innovation in antibody-drug conjugates and in vivo CAR-T therapy


AbbVie signals major oncology momentum at ASCO
R&D | May 25, 2026

AbbVie signals major oncology momentum at ASCO

With standout ADC and t-cell engager response data across hard-to-treat cancers


Health ministry classifies Pregabalin under Schedule H1 to curb misuse
Policy | May 23, 2026

Health ministry classifies Pregabalin under Schedule H1 to curb misuse

New regulation mandates stricter prescription monitoring, sales record maintenance, and enhanced compliance across the pharmaceutical supply chain